STAT3 and medical procedure: To the best of our knowledge, this is the first report identifying α-hederin as a promising preventive agent for inhibiting colorectal tumorigenesis by directly targeting USP5, reducing its expression and interaction with STAT3, thereby disrupting USP5-mediated STAT3 deubiquitination.